Tag:
Dana-Farber Cancer Institute
Latest Headlines
Latest Headlines
Scoring genes in ovarian cancer could predict treatment response
Researchers from the Dana-Farber Cancer Institute have created a score based on the expression of genes involved in the repair of DNA after platinum-based treatment to see if this could predict the response, but the take on this is mixed.
Cadre of scientists compile volumes of data on cancer cell weaknesses
So you're a researcher or doctor, trying to pick a drug that would work best targeting a specific cancer subtype. What to do? You now have "encyclopedias" of sorts with which you can look for the information.
Gene study finds tumor-cell flaw possibly vulnerable to Pfizer, AZ cancer meds
More evidence that drugs and diagnostics will be playing together often: Researchers sequencing genes in colon and lung tumors found mutations that could be targeted with existing drugs. The study
DNA sequencing exposes new uses for Pfizer targeted cancer drugs
As pharma companies expand their use of DNA sequencing for drug R&D, researchers have uncovered some potential new targets for existing cancer drugs that are likely to spur further use of
Texas rustles Dana-Farber science team to spearhead $75M cancer R&D effort
With an eye to ramping up some ambitious new R&D work on a new generation of cancer therapies, Houston's renowned MD Anderson Cancer Center has poached 55 scientists from the equally well known
UPDATED: Dana-Farber, Brigham and Women's further personalized medicine via cancer genome database
The Dana-Farber Cancer Institute and Brigham and Women's Hospital have taken on a seemingly Herculean task with their new genomic database, called Profile. By compiling genetic data on nearly every
Dana-Farber finds new AIDS vax target
The Dana-Farber Cancer Institute is making progress toward an AIDS vaccine thanks to a relatively stable portion of the virus' protein envelope. By targeting the protein strand, called the V3 loop,
